222 related articles for article (PubMed ID: 22452132)
1. [Is the use of vitamin K antagonists harmful in patients with CDK?].
Pham TT; Saudan P
Rev Med Suisse; 2012 Feb; 8(330):462-5. PubMed ID: 22452132
[TBL] [Abstract][Full Text] [Related]
2. [Educational and information needs of patients under vitamin K antagonist therapy].
Ben Jeddou K; Ben M'Barka F; Boukhris I; Arfaoui H; Baccar H; Khalfalah N; Ouhachi Z
Rev Med Interne; 2018 Jul; 39(7):546-550. PubMed ID: 29789192
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of patients' knowledge on their vitamin K antagonist treatment.
Mzoughi K; Zairi I; BenGhorbel F; Ben Kilani M; Kamoun S; Ben Moussa F; Fennira S; Kraiem S
Tunis Med; 2018 Mar; 96(3):182-186. PubMed ID: 30325485
[TBL] [Abstract][Full Text] [Related]
4. [Prescription and monitoring of anticoagulant therapies].
Frank M; Fischer AM
Rev Prat; 2012 Jun; 62(6):849-57. PubMed ID: 22838290
[No Abstract] [Full Text] [Related]
5. Pulmonary embolism in patients over 90 years of age.
Monreal M; López-Jiménez L
Curr Opin Pulm Med; 2010 Sep; 16(5):432-6. PubMed ID: 20671514
[TBL] [Abstract][Full Text] [Related]
6. [Anticoagulation of older patients: what is new?].
Lafuente-Lafuente C; Pautas É; Belmin J
Presse Med; 2013 Feb; 42(2):187-96. PubMed ID: 23312927
[TBL] [Abstract][Full Text] [Related]
7. [Management of vitamin K antagonists in the elderly].
Belleville T; Pautas É; Gaussem P; Siguret V
Ann Biol Clin (Paris); 2014; 72(2):185-92. PubMed ID: 24736138
[TBL] [Abstract][Full Text] [Related]
8. [Anticoagulant clinics in France? Which usefulness now and for the future?].
Mahé I
Rev Med Interne; 2013 Sep; 34(9):513-4. PubMed ID: 23517772
[No Abstract] [Full Text] [Related]
9. [Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists].
Cambus JP; Magnin D; Ambid-Lacombe C; Bura A; Desgrippes F; Schneller JM; Benhamou Y; Flaujac C; Horellou MH; De Raucourt E; Kaczan D; Astoul JM; Siguret V
Rev Med Interne; 2013 Sep; 34(9):515-21. PubMed ID: 23523077
[TBL] [Abstract][Full Text] [Related]
10. Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists.
Chatrou ML; Winckers K; Hackeng TM; Reutelingsperger CP; Schurgers LJ
Blood Rev; 2012 Jul; 26(4):155-66. PubMed ID: 22520397
[TBL] [Abstract][Full Text] [Related]
11. [Vitamine K antagonists overdose: Physician adherence to the French guidelines].
Oliosi E; Pointeau O; Mazoyer E; Le Jeune S; Giroux-Leprieur B; Dhôte R; Mourad JJ
Rev Med Interne; 2018 May; 39(5):321-325. PubMed ID: 29550092
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic nephropathy induced by fluindione must be addressed.
Cam G; Kwetcheu AT; Vigneau C; Siohan P; Queffeulou G; Gatault P; Laruelle E; Crémault A; Le Cacheux P; Rioux-Leclercq N; Renaudineau E
Nephrol Dial Transplant; 2012 Apr; 27(4):1554-8. PubMed ID: 21931126
[TBL] [Abstract][Full Text] [Related]
13. [New oral anticoagulants (NOACs): happy or not happy?].
Bergmann JF
Presse Med; 2013 Oct; 42(10):1295-7. PubMed ID: 24160349
[No Abstract] [Full Text] [Related]
14. [Massive right auricular and ventricular thrombosis after Kaskadil administration in a patient with an overdose of antivitamin K].
Bonnet A; Rimmelé T; Crozon J; Pruvot S
Ann Fr Anesth Reanim; 2008 Apr; 27(4):348-9. PubMed ID: 18403177
[No Abstract] [Full Text] [Related]
15. Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
Cadiou G; Varin R; Levesque H; Grassi V; Benichou J; Tiret I; Dieu B; Lecam-Duchez V; Borg JY; Muller JM; Benhamou Y; Marie I
Thromb Haemost; 2008 Oct; 100(4):685-92. PubMed ID: 18841293
[TBL] [Abstract][Full Text] [Related]
16. [Anticoagulants. Antivitamins K: principles and rules of use, posology].
Mismetti P; Decousus H
Rev Prat; 1995 Apr; 45(8):1014-7. PubMed ID: 7761767
[No Abstract] [Full Text] [Related]
17. [Heterogeneity in the handling of vitamin-K-antagonists and of INR: the example of Quercy-Rouergue].
Watine J; Mokaddem W; Carriere P; Couaillac JP; Kristoffersen AH; Thue G; Sandberg S
Ann Biol Clin (Paris); 2013; 71(6):707-16. PubMed ID: 24342793
[TBL] [Abstract][Full Text] [Related]
18. [Prescription and follow-up of antithrombotic treatment with vitamin K antagonists].
Bounhoure JP
Bull Acad Natl Med; 2013 Nov; 197(8):1561-70; discussion 1570-1. PubMed ID: 26021177
[TBL] [Abstract][Full Text] [Related]
19. Reversible cerebral vasoconstriction syndrome and antivitamin K anticoagulation: challenges of an unusual association.
Nasri A; Mansour M; Kacem A; Zaouali J; Mrissa R
Neurol Sci; 2017 Sep; 38(9):1715-1717. PubMed ID: 28502058
[No Abstract] [Full Text] [Related]
20. [Anticoagulant therapy complicated by ureteric haematoma: A case report].
Cabaniols L; Laffargue G; Gres P; Guiter J; Thuret R
Prog Urol; 2008 Sep; 18(8):550-2. PubMed ID: 18760747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
